{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T21:18:15Z","timestamp":1778620695289,"version":"3.51.4"},"reference-count":28,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,12,29]],"date-time":"2023-12-29T00:00:00Z","timestamp":1703808000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100022939","name":"Zell Family Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100022939","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000005","name":"U.S. Department of Defense","doi-asserted-by":"publisher","award":["W81XWH-17-1-0382"],"award-info":[{"award-number":["W81XWH-17-1-0382"]}],"id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Contemporary Clinical Trials"],"published-print":{"date-parts":[[2024,2]]},"DOI":"10.1016\/j.cct.2023.107423","type":"journal-article","created":{"date-parts":[[2023,12,25]],"date-time":"2023-12-25T10:43:20Z","timestamp":1703501000000},"page":"107423","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Statin therapy in patients with early-stage autosomal dominant polycystic kidney disease: Design and baseline characteristics"],"prefix":"10.1016","volume":"137","author":[{"given":"Berenice Y.","family":"Gitomer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Diana","family":"George","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erin","family":"Coleman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kristen L.","family":"Nowak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Taylor","family":"Struemph","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Melissa A.","family":"Cadnapaphornchai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nayana U.","family":"Patel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Jovanovich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jelena","family":"Klawitter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Beverly","family":"Farmer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Ostrow","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhiying","family":"You","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michel","family":"Chonchol","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cct.2023.107423_bb0005","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1056\/NEJMcp0804458","article-title":"Clinical practice. Autosomal dominant polycystic kidney disease","volume":"359","author":"Grantham","year":"2008","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.cct.2023.107423_bb0010","first-page":"S93","article-title":"Mechanisms of progression in autosomal dominant polycystic kidney disease","volume":"63","author":"Grantham","year":"1997","journal-title":"Kidney Int. Suppl."},{"key":"10.1016\/j.cct.2023.107423_bb0015","doi-asserted-by":"crossref","first-page":"2122","DOI":"10.1056\/NEJMoa054341","article-title":"Volume progression in polycystic kidney disease","volume":"354","author":"Grantham","year":"2006","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.cct.2023.107423_bb0020","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1038\/ki.1992.195","article-title":"Factors affecting the progression of renal disease in autosomal-dominant polycystic kidney disease","volume":"41","author":"Gabow","year":"1992","journal-title":"Kidney Int."},{"key":"10.1016\/j.cct.2023.107423_bb0025","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1681\/ASN.2017050483","article-title":"Genetic complexity of autosomal dominant polycystic kidney and liver diseases","volume":"29","author":"Cornec-Le Gall","year":"2018","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.cct.2023.107423_bb0030","doi-asserted-by":"crossref","first-page":"2407","DOI":"10.1056\/NEJMoa1205511","article-title":"Tolvaptan in patients with autosomal dominant polycystic kidney disease","volume":"367","author":"Torres","year":"2012","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.cct.2023.107423_bb0035","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/0272-6386(95)90497-2","article-title":"Effect of lovastatin on the development of polycystic kidney disease in the Han:SPRD rat","volume":"26","author":"Gile","year":"1995","journal-title":"Am. J. Kidney Dis."},{"key":"10.1016\/j.cct.2023.107423_bb0040","doi-asserted-by":"crossref","first-page":"F854","DOI":"10.1152\/ajprenal.00059.2007","article-title":"Effect of statin and angiotensin-converting enzyme inhibition on structural and hemodynamic alterations in autosomal dominant polycystic kidney disease model","volume":"293","author":"Zafar","year":"2007","journal-title":"Am. J. Physiol. Ren. Physiol."},{"key":"10.1016\/j.cct.2023.107423_bb0045","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.cct.2005.01.001","article-title":"Design and baseline characteristics of participants in the study of antihypertensive therapy in children and adolescents with autosomal dominant polycystic kidney disease (ADPKD)","volume":"26","author":"Cadnapaphornchai","year":"2005","journal-title":"Contemp. Clin. Trials"},{"key":"10.1016\/j.cct.2023.107423_bb0050","doi-asserted-by":"crossref","first-page":"889","DOI":"10.2215\/CJN.08350813","article-title":"Effect of pravastatin on total kidney volume, left ventricular mass index, and microalbuminuria in pediatric autosomal dominant polycystic kidney disease","volume":"9","author":"Cadnapaphornchai","year":"2014","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"10.1016\/j.cct.2023.107423_bb0055","doi-asserted-by":"crossref","first-page":"2152","DOI":"10.1093\/ndt\/16.11.2152","article-title":"Effect of simvastatin on renal function in autosomal dominant polycystic kidney disease","volume":"16","author":"van Dijk","year":"2001","journal-title":"Nephrol. Dial. Transplant."},{"key":"10.1016\/j.cct.2023.107423_bb0060","first-page":"109","article-title":"Effect of statin therapy on the progression of autosomal dominant polycystic kidney disease. A secondary analysis of the HALT PKD trials","volume":"13","author":"Brosnahan","year":"2017","journal-title":"Curr. Hypertens. Rev."},{"key":"10.1016\/j.cct.2023.107423_bb0065","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.2215\/CJN.11331114","article-title":"Pravastatin therapy and biomarker changes in children and young adults with autosomal dominant polycystic kidney disease","volume":"10","author":"Klawitter","year":"2015","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"10.1016\/j.cct.2023.107423_bb0070","doi-asserted-by":"crossref","first-page":"604","DOI":"10.7326\/0003-4819-150-9-200905050-00006","article-title":"A new equation to estimate glomerular filtration rate","volume":"150","author":"Levey","year":"2009","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.cct.2023.107423_bb0075","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1681\/ASN.2008050507","article-title":"Unified criteria for ultrasonographic diagnosis of ADPKD","volume":"20","author":"Pei","year":"2009","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.cct.2023.107423_bb0080","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1161\/01.CIR.102.11.1270","article-title":"Aging, habitual exercise, and dynamic arterial compliance","volume":"102","author":"Tanaka","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.cct.2023.107423_bb0085","doi-asserted-by":"crossref","first-page":"2255","DOI":"10.1056\/NEJMoa1402685","article-title":"Blood pressure in early autosomal dominant polycystic kidney disease","volume":"371","author":"Schrier","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.cct.2023.107423_bb0090","doi-asserted-by":"crossref","first-page":"719","DOI":"10.2215\/CJN.03750708","article-title":"MRI-based kidney volume measurements in ADPKD: reliability and effect of gadolinium enhancement","volume":"4","author":"Bae","year":"2009","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"10.1016\/j.cct.2023.107423_bb0095","doi-asserted-by":"crossref","first-page":"112","DOI":"10.2215\/CJN.00910306","article-title":"Magnetic resonance measurements of renal blood flow and disease progression in autosomal dominant polycystic kidney disease","volume":"2","author":"Torres","year":"2007","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"10.1016\/j.cct.2023.107423_bb0100","doi-asserted-by":"crossref","first-page":"2214","DOI":"10.1046\/j.1523-1755.2003.00326.x","article-title":"Magnetic resonance measurements of renal blood flow as a marker of disease severity in autosomal-dominant polycystic kidney disease","volume":"64","author":"King","year":"2003","journal-title":"Kidney Int."},{"key":"10.1016\/j.cct.2023.107423_bb0105","first-page":"S151","article-title":"Measurement of glomerular filtration rate","volume":"63","author":"Gaspari","year":"1997","journal-title":"Kidney Int. Suppl."},{"key":"10.1016\/j.cct.2023.107423_bb0110","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1016\/S0272-6386(03)00022-2","article-title":"Ambulatory GFR measurement with cold iothalamate in adults with chronic kidney disease","volume":"41","author":"Agarwal","year":"2003","journal-title":"Am. J. Kidney Dis."},{"key":"10.1016\/j.cct.2023.107423_bb0115","doi-asserted-by":"crossref","first-page":"2305","DOI":"10.1681\/ASN.2009020171","article-title":"Measured GFR as a confirmatory test for estimated GFR","volume":"20","author":"Stevens","year":"2009","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.cct.2023.107423_bb0120","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1053\/ajkd.2000.8237","article-title":"Serum cystatin C as a new marker for noninvasive estimation of glomerular filtration rate and as a marker for early renal impairment","volume":"36","author":"Coll","year":"2000","journal-title":"Am. J. Kidney Dis."},{"key":"10.1016\/j.cct.2023.107423_bb0125","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1007\/s10157-019-01748-z","article-title":"Dysmetabolic markers predict outcomes in autosomal dominant polycystic kidney disease","volume":"23","author":"Kocyigit","year":"2019","journal-title":"Clin. Exp. Nephrol."},{"key":"10.1016\/j.cct.2023.107423_bb0130","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1194\/jlr.P042176","article-title":"Bioactive lipid mediators in polycystic kidney disease","volume":"55","author":"Klawitter","year":"2013","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.cct.2023.107423_bb0135","doi-asserted-by":"crossref","first-page":"F1198","DOI":"10.1152\/ajprenal.00327.2014","article-title":"Endothelial dysfunction and oxidative stress in polycystic kidney disease","volume":"307","author":"Klawitter","year":"2014","journal-title":"Am. J. Physiol. Ren. Physiol."},{"key":"10.1016\/j.cct.2023.107423_bb0140","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1111\/j.1751-5823.2003.tb00213.x","article-title":"Multiple imputation: theory and method","volume":"71","author":"Zhang","year":"2003","journal-title":"Int. Stat. Rev."}],"container-title":["Contemporary Clinical Trials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1551714423003464?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1551714423003464?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T20:38:20Z","timestamp":1778618300000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1551714423003464"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2]]},"references-count":28,"alternative-id":["S1551714423003464"],"URL":"https:\/\/doi.org\/10.1016\/j.cct.2023.107423","relation":{},"ISSN":["1551-7144"],"issn-type":[{"value":"1551-7144","type":"print"}],"subject":[],"published":{"date-parts":[[2024,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Statin therapy in patients with early-stage autosomal dominant polycystic kidney disease: Design and baseline characteristics","name":"articletitle","label":"Article Title"},{"value":"Contemporary Clinical Trials","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cct.2023.107423","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"107423"}}